Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · IEX Real-Time Price · USD
1.330
+0.040 (3.10%)
May 3, 2024, 2:14 PM EDT - Market open
Ekso Bionics Holdings Revenue
Ekso Bionics Holdings had revenue of $17.91M in the twelve months ending March 31, 2024, with 23.82% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.76M, a -8.88% decrease year-over-year. In the year 2023, Ekso Bionics Holdings had annual revenue of $18.28M with 41.57% growth.
Revenue (ttm)
$17.91M
Revenue Growth
+23.82%
P/S Ratio
1.31
Revenue / Employee
$255,900
Employees
70
Market Cap
23.63M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 18.28M | 5.37M | 41.57% |
Dec 31, 2022 | 12.91M | 1.67M | 14.81% |
Dec 31, 2021 | 11.25M | 2.36M | 26.62% |
Dec 31, 2020 | 8.88M | -5.04M | -36.18% |
Dec 31, 2019 | 13.92M | 2.59M | 22.81% |
Dec 31, 2018 | 11.33M | 3.98M | 54.11% |
Dec 31, 2017 | 7.35M | -6.87M | -48.29% |
Dec 31, 2016 | 14.22M | 5.56M | 64.20% |
Dec 31, 2015 | 8.66M | 3.33M | 62.59% |
Dec 31, 2014 | 5.33M | 2.03M | 61.33% |
Dec 31, 2013 | 3.30M | 596.00K | 22.03% |
Dec 31, 2012 | 2.71M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cue Health | 70.94M |
Exagen | 52.55M |
Sol-Gel Technologies | 1.55M |
OncoCyte | 1.50M |
Aptorum Group | 431.38K |
Bullfrog AI | 65.00K |
Benitec Biopharma | 61.00K |
EKSO News
- 3 days ago - Ekso Bionics Announces First Quarter 2024 Financial Results - GlobeNewsWire
- 11 days ago - Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024 - GlobeNewsWire
- 21 days ago - Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal - GlobeNewsWire
- 2 months ago - Ekso Bionics Reports Record Annual Revenue of $18.3 Million - GlobeNewsWire
- 4 months ago - Ekso Bionics Launches GaitCoach Software for EksoNR - GlobeNewsWire
- 4 months ago - Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 6 months ago - Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29 - GlobeNewsWire
- 6 months ago - Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal - GlobeNewsWire